PIC Therapeutics
PrivateLast Round
Series A
Oct 19, 2022
Total Funding Raised
$40M
Company Overview
PIC Therapeutics operates in Healthcare & Life Sciences and is based in Natick, Massachusetts. Its latest recorded funding round was a Series A round in October 2022.
PIC Therapeutics is a biotechnology company that develops precision-based small molecule therapeutics targeting the pre-initiation complex to inhibit oncogene protein production for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PIC Therapeutics Comparables
Compare PIC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribonexus | 81% | |
| Pfizer | 72% | |
| H3 Biomedicine Inc. | 69% |
For institutional investors. Book with your work email.
PIC Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 19, 2022 | ||||
| Seed | Apr 15, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PIC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advent Life Sciences | Series A, Seed |
| OrbiMed | Series A |
| Lumira Ventures | Series A |
| Harrington Discovery Institute | Series A |
PIC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PIC Therapeutics's valuation, stock price, and market status.
Is PIC Therapeutics a public or private company?
PIC Therapeutics is a private company.
What is the current stock price of PIC Therapeutics?
PIC Therapeutics is a private company, so its shares have no public market price. Caplight tracks PIC Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PIC Therapeutics worth (valuation)?
Valuation information for PIC Therapeutics is not publicly available.
Can I buy PIC Therapeutics stock?
PIC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PIC Therapeutics's last funding round?
PIC Therapeutics's most recent funding round was Series A on October 19, 2022.
Who are the main investors in PIC Therapeutics?
Key investors in PIC Therapeutics include Advent Life Sciences, OrbiMed.
Will PIC Therapeutics IPO soon?
No public IPO plans have been announced for PIC Therapeutics.
How can I track PIC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PIC Therapeutics's shares on secondary markets.